Kite Pharma, Inc. Deferred Tax Assets, Valuation Allowance

Kite Pharma, Inc. Deferred Tax Assets, Valuation Allowance

Kite Pharma, Inc. had Deferred Tax Assets, Valuation Allowance of $111.83 million as of 2016-12-31, per its 10-K filed 2017-02-28.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2017-02-28

• 2016-12-31: Deferred Tax Assets, Valuation Allowance $111.83M.
• 2015-12-31: Deferred Tax Assets, Valuation Allowance $40.16M.
• 2014-12-31: Deferred Tax Assets, Valuation Allowance $17.08M.
• 2013-12-31: Deferred Tax Assets, Valuation Allowance $5.44M.